Placebo News and Research

RSS

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

The research was part of the Platelet-Oriented Inhibition in New TIA and minor ischemic stroke trial -- a randomized, double-blind, placebo-controlled trial conducted between May 2010 and December 2017.

16 May 2018

Study: Drug used to treat blood loss may be beneficial for some stroke patients

Patients with stroke caused by bleeding on the brain may benefit from receiving a drug currently used to treat blood loss from major trauma and bleeding after childbirth, an international trial has revealed.

16 May 2018

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Arrowhead Pharmaceuticals Inc. today announced that it has dosed the first 3 hepatitis B virus patients in the multiple-ascending dose portion of its ongoing Phase 1/2 study of ARO-HBV, the company's third generation subcutaneously administered RNA interference therapeutic being developed as a potentially curative therapy for patients with chronic HBV infection.

14 May 2018

Human papilloma virus vaccines can protect against cervical lesions in young women

New evidence published today in the Cochrane Library shows that human papilloma virus vaccines protect against cervical lesions in young women, particularly in those who are vaccinated between the ages of 15 and 26.

9 May 2018

Study compares effectiveness of vaginal estradiol tablets and moisturizers in treating vulvovaginal problems

A new study reports that vaginal estradiol tablets just might be what's needed to relieve vulvovaginal problems and improve overall quality of life.

9 May 2018

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

Erythropoietin helps to protect and repair vulnerable brains though it remains a mystery how the anemia drug does so.

7 May 2018

Phase 2 clinical study of universal influenza vaccine begins in the United States

A Phase 2 clinical trial of an investigational universal influenza vaccine intended to protect against multiple strains of the virus has begun in the United States.

4 May 2018

Maternal placentophagy does not cause harm to newborn babies, study finds

The largest study of its kind found mothers who consumed their placenta passed on no harm to their newborn babies when compared to infants of mothers who did not consume their placenta.

3 May 2018

Brain stimulation may offer new way to prevent suicide in people with hard-to-treat depression

A specific kind of brain stimulation is effective in reducing suicidal thinking in a significant portion of people with hard-to-treat depression, according to a new CAMH study published in The Journal of Clinical Psychiatry.

3 May 2018

Nonsteroidal anti-inflammatory drug ranked to be most effective in treating knee OA

An estimated 45 percent of people are at risk of developing knee osteoarthritis (OA) in their lifetime. According to a network meta-analysis research article published in the May 1, 2018 issue of the Journal of the American Academy of Orthopaedic Surgeons, the nonsteroidal anti-inflammatory drug naproxen was ranked most effective in individual knee OA treatment for improving both pain and function, and is considered a relatively safe and low-cost treatment method.

2 May 2018

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

A new experimental study has tested the safety and effectiveness of MDMA-assisted psychotherapy in 26 service personnel with post-traumatic stress disorder (PTSD).

2 May 2018

Significant update to PROGRESS-CTO International Registry presented at SCAI Scientific Sessions 2018

A significant update to the PROGRESS-CTO (PROspective Global Registry for the Study of Chronic Total Occlusion Intervention) International Registry was presented today as late-breaking clinical science at Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions 2018.

28 Apr 2018

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).

28 Apr 2018

New treatment option appears promising for patients with glucocorticoid-induced osteoporosis

About one in every 100 people in the world takes glucocorticoids long term to treat immune-mediated diseases. However, glucocorticoids, such as prednisone, have a side effect -- they induce the bone loss called osteoporosis, causing an estimated yearly bone fracture rate of 5 percent.

27 Apr 2018

Vitamin B6 could help people to recall their dreams

New research from the University of Adelaide has found that taking vitamin B6 could help people to recall their dreams.

27 Apr 2018

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

Researchers at University of California San Diego School of Medicine are preparing a first-of-its-kind, multidisciplinary investigation to determine if and how cannabidiol, a non-psychoactive compound found in the cannabis plant, provides therapeutic benefit to children with severe symptoms of autism spectrum disorder.

27 Apr 2018

Probiotics may be safe, low-cost prevention tool for Clostridium difficile infections

Probiotics may be a relatively safe, simple, and low-cost solution for preventing Clostridium difficile infections in hospital settings, according to two studies published today in Infection Control & Hospital Epidemiology, the journal of the Society for Healthcare Epidemiology of America.

26 Apr 2018

FDA re-examining safety of new drug approved for Parkinson’s disease psychosis

The United States Food and Drug Administration (FDA) is looking again at the safety of a drug Nuplazid that was approved earlier in 2016. This is the only drug that has been approved for the treatment of psychiatric manifestations such as hallucinations and delusions that are associated with Parkinson's disease.

26 Apr 2018

New app could improve safety of cannabis use

Although cannabis, also known as marijuana, has been shown to impair memory, reaction time and attention, it is difficult to assess this impairment in a natural setting. Researchers have developed a prototype app called 'Am I Stoned' that could help cannabis users understand how the drug is affecting them through a series of phone-based tasks.

25 Apr 2018

Clinical trial to examine stem cell therapy for treatment, prevention of complications after traumatic injury

The University of Texas Health Science Center at Houston has received funding through a public/private partnership for the first-ever clinical trial investigating a stem cell therapy for early treatment and prevention of complications after severe traumatic injury.

23 Apr 2018

Placebo News and Research

Taking clot-preventing drug with aspirin may lower risk of major stroke, finds study

Study: Drug used to treat blood loss may be beneficial for some stroke patients

Phase 1/2 study evaluates safety, tolerability of multiple-ascending doses of ARO-HBV in hepatitis B patients

Human papilloma virus vaccines can protect against cervical lesions in young women

Study compares effectiveness of vaginal estradiol tablets and moisturizers in treating vulvovaginal problems

EPO's neuroprotective effect in preemies may be mediated by epigenetic regulation of genes

Phase 2 clinical study of universal influenza vaccine begins in the United States

Maternal placentophagy does not cause harm to newborn babies, study finds

Brain stimulation may offer new way to prevent suicide in people with hard-to-treat depression

Nonsteroidal anti-inflammatory drug ranked to be most effective in treating knee OA

Study examines effectiveness of MDMA-assisted psychotherapy in service personnel with PTSD

Significant update to PROGRESS-CTO International Registry presented at SCAI Scientific Sessions 2018

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

New treatment option appears promising for patients with glucocorticoid-induced osteoporosis

Vitamin B6 could help people to recall their dreams

Study to examine whether cannabidiol provides therapeutic benefit to children with autism

Probiotics may be safe, low-cost prevention tool for Clostridium difficile infections

FDA re-examining safety of new drug approved for Parkinson’s disease psychosis

New app could improve safety of cannabis use

Clinical trial to examine stem cell therapy for treatment, prevention of complications after traumatic injury

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News